Marinus Pharmaceuticals Inc (MRNS) USD0.001

Sell:$1.39Buy:$1.43$0.00 (0.00%)

Prices delayed by at least 15 minutes
Sell:$1.39
Buy:$1.43
Change:$0.00 (0.00%)
Prices delayed by at least 15 minutes
Sell:$1.39
Buy:$1.43
Change:$0.00 (0.00%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 February 2024
Christina (Christy) ShaferChief Level Officer
Sell
Tax related
2,153$9.56$20,582.6860,308
20 February 2024
Martha E ManningVice President
Sell
Tax related
1,894$9.57$18,125.5852,966
16 February 2024
Scott BraunsteinExecutive Chairman
Sell
Tax related
11,850$9.94$117,789.00223,512
16 February 2024
Steven PfanstielCFO
Sell
Tax related
3,092$9.97$30,827.2471,697
16 February 2024
Joseph HulihanChief Level Officer
Sell
Tax related
2,814$9.98$28,083.7266,635
8 August 2023
Scott BraunsteinExecutive Chairman
Sell
Tax related
30$8.94$268.20160,762
8 August 2023
Steven PfanstielCFO
Sell
Tax related
14$8.93$125.0249,324
8 August 2023
Joseph HulihanChief Level Officer
Sell
Tax related
13$8.93$116.0947,614
8 August 2023
Christina (Christy) ShaferChief Level Officer
Sell
Tax related
11$8.93$98.2340,626
8 August 2023
Martha E ManningVice President
Sell
Tax related
11$8.93$98.2333,025

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 February 2024
Scott BraunsteinExecutive Chairman
Sell
Tax related
11,850$9.94$117,789.00223,512
7 August 2023
Scott BraunsteinExecutive Chairman
Sell
Tax related
6,413$9.55$61,244.15160,792
16 February 2024
Steven PfanstielCFO
Sell
Tax related
3,092$9.97$30,827.2471,697
16 February 2024
Joseph HulihanChief Level Officer
Sell
Tax related
2,814$9.98$28,083.7266,635
7 August 2023
Joseph HulihanChief Level Officer
Sell
Tax related
2,889$9.55$27,589.9547,627

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.